Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters

Phase 4

Completed

• Conditions: Carpal Tunnel Syndrome
• Interventions: Drug: Normal saline; Drug: Ropivacaine 0.2%; Drug: Ropivacaine 0.75%

• Registration Number: NCT00678314
• Lead Sponsor: Region Örebro County

Brief Summary

This study was done with the primary aim of assessing the efficacy (as calculated by pain intensity difference) of patient controlled regional analgesia (PCRA) technique against oral analgesics, which has been the standard of care at our hospital. Secondary objectives were to analyze the volume and dose of LA that should be given, patient satisfaction and the long-term outcome for patients treated with the PCRA technique.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-01
• Primary Completion: 2006-01
• Study Completion: 2006-02
• Status Verified: 2008-05
• Study First Submitted: 2008-05-13
• Study First Submitted QC: 2008-05-13
• Last Update Submitted: 2008-05-13
• Study First Posted: 2008-05-15
• Last Update Posted: 2008-05-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

• Patients with clinically established carpel tunnel syndrome
• Surgery performed under local anesthesia

Exclusion Criteria

• Chronic pain requiring analgesics

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group C	Normal saline	-
Group A	Ropivacaine 0.2%	-
Group B	Ropivacaine 0.75%	-

Primary Outcome Measures

Name	Time	Method
This study was done with the primary aim of assessing the efficacy (as calculated by pain intensity difference) of patient controlled regional analgesia (PCRA) technique against oral analgesics, which has been the standard of care at our hospital.	24 h

Secondary Outcome Measures

Name	Time	Method
Secondary objectives were to analyze the volume and dose of LA that should be given, patient satisfaction and the long-term outcome for patients treated with the PCRA technique.	Up to 1 yr after surgery

Trial Locations

Locations (1)

Örebro University Hospital; 🇸🇪 Örebro, Sweden